Strata Critical Medical, Inc.
SRTA
$5.19
$0.163.18%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 61.43% | 46.99% | 51.30% | -37.03% | -4.52% |
| Total Depreciation and Amortization | -7.64% | -14.01% | -16.16% | -14.42% | -1.23% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -44.17% | 9.02% | -6.50% | 13,296.21% | 502.89% |
| Change in Net Operating Assets | -46.45% | 204.87% | 55.34% | -98.42% | 65.65% |
| Cash from Operations | 108.97% | 141.19% | 92.21% | 68.61% | 64.40% |
| Capital Expenditure | -6.31% | -1,333.87% | -1,363.96% | -1,155.53% | -1,084.61% |
| Sale of Property, Plant, and Equipment | -40.58% | -86.96% | -90.58% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 175.81% | 8.00% | 68.29% | 19.99% | 137.95% |
| Cash from Investing | 761.04% | -120.38% | -105.95% | -128.14% | 104.34% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00% | 28.04% | 140.00% | 89.86% | 108.06% |
| Repurchase of Common Stock | -671.11% | -9,896.08% | -3,959.59% | -1,571.31% | -402.68% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -744.29% | -201,280.00% | -7,477.63% | -3,500.00% | -494.47% |
| Foreign Exchange rate Adjustments | 293.28% | 175.79% | -21.21% | -- | -240.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 389.76% | 58.81% | 39.14% | -14.67% | 92.59% |